Careers

Passionate to help us save lives?

Intensive care medicine

Biotest produces several human blood plasma derived concentrates for intensive care medicines. These include Pentaglobin, an IgM enriched immunoglobulin, and other intravenously administered solutions, for the treatment of severe bacterial infections, coagulation disorders, and volume- or protein-substitution.

Haematology

For the treatment of Haemophilia A and B, Biotest AG manufactures two preparations which derive from human plasma and are designed for intravenous injection.

Clinical immunology

Biotest produces several antibody concentrates from human blood plasma which are available as ready-to-use solutions. Biotest offers the IVIG preparation Intratect and different hyperimmunoglobulins with increased antibody titers against cytomegaloviruses (CMV), hepatitis B viruses (HBV) or varicella zoster viruses (VZV).

Human Albumin for manufacturing and research use

Through its wide range of biological functions, its stability and high solubility, Biotest Human Serum Albumin is suitable for use as a multifunctional excipient for biotechnological,  pharmaceutical and diagnostic applications. It is manufactured in a GMP compliant, state-of-the-art facility and complies with the regulatory requirements of multiple health authorities.

Investor Relations

The primary objective of our Investor Relations activities is an open and up-to-date dialogue with the financial community.

Renate & Hans Schleussner Award

Third Renate & Hans Schleussner Research Award 2023/2024 on Hyper-Immunoglobulins now online.